Keyphrases
Cell Reprogramming
100%
Heart Repair
100%
Induced Pluripotent Stem Cells (iPSCs)
100%
Stem Cell Lines
100%
Dand5
100%
Pluripotent State
66%
Cardiomyocytes
54%
Gene Editing
54%
Cardiac Remodeling
50%
Cardiac Regeneration
50%
MicroRNA
50%
Damaged Tissue
50%
Cell Plasticity
50%
Clinical Application
50%
Fibroblasts
50%
Safety Concerns
50%
Myocardial Infarction
50%
Cardiac Function
50%
Therapeutic Approaches
50%
Major Contributor
50%
Pro-regenerative
50%
Cardiovascular Disease
50%
Current Therapeutics
50%
Innovative Approach
50%
Cardiac Tissue
50%
Promising Solutions
50%
Reprogramming Efficiency
50%
Cell Proliferation
50%
Reprogramming Factors
50%
Cell Lineage
50%
Laterality Defects
50%
Small Molecules
50%
Gene-edited
50%
Congenital Cardiac Anomaly
50%
Cell Transplantation
50%
Cell Source
50%
In Situ Cell
50%
Cell Maturation
50%
Leading Causes of Death
50%
Regress
50%
Heart Transplant
50%
Reconstitution
50%
Cardiac Differentiation
50%
Isogenic
20%
Congenital Heart Disease
20%
Human Disease
16%
Ectoderm
16%
Normal Karyotype
16%
Endoderm
16%
Mesoderm
16%
Biochemistry, Genetics and Molecular Biology
Cell Dedifferentiation
100%
Human Induced Pluripotent Stem Cell
100%
Reprogramming
100%
Nuclear Reprogramming
100%
Transdifferentiation
100%
Stem Cell Line
100%
Cardiac Muscle Cell
65%
Genome Editing
53%
Cell Maturation
50%
Small Molecule
50%
Cell Lineage
50%
MicroRNA
50%
Cell Proliferation
50%
Heart Function
50%
Cell Transplantation
50%
Solution and Solubility
50%
Cell Plasticity
50%
Hemispheric Dominance
50%
Fibroblast
50%
CRISPR/Cas9
20%
Ectoderm
16%
Endoderm
16%
Epiblast
16%
Mesoderm
16%
Karyotype
16%
Immunology and Microbiology
Cell Transdifferentiation
100%
Nuclear Reprogramming
100%
Cell Dedifferentiation
100%
Gene Editing
50%
Cell Plasticity
50%
Cell Maturation
50%
Cell Transplantation
50%
Cardiac Muscle Cell
50%
Cell Lineage
50%
Solution and Solubility
50%
Heart Function
50%
Cell Proliferation
50%
In Vitro
50%
Fibroblast
50%
